
Augmodo Raises $37.5M to Modernize and Grow Spatial AI Tech
"We've tried other solutions but they only provide a rearview snapshot – Augmodo allows us to be armed with 24/7 strategic information so we can be agile to customer and store demands – Augmodo is the future."
Share
Retail will be the most disrupted industry by spatial AI – it has the largest physical workforce and physical data problems. Founded in 2023, Augmodo's wearable SmartBadges™ create live 3D store maps powered by a spatial AI assistant, which recommends actions to store associates, solving various issues on retail floors. Augmodo's technology increases efficiency and makes store associates even more valuable – it helps them restock shelves, place orders, and improve compliance – saving stores time and money and improving retailer, associate, brand, and shopper experiences.
Compared to other CV solutions, like robots, SmartBadges collect ten times more frequent data, are 100 times cheaper and set-up speed and simplicity are unrivaled – hardware is installed in less than 20 minutes and results in 100% passive data collection – associates simply walk the aisles as they normally do while the SmartBadge conducts high-frequency scans hundreds of times daily, for the benefit of retailers and brands alike.
'Augmodo was created to transform the physical world of shopping with spatial computing and wearables. Initially, we thought it would take many years to show this much progress toward our goal,' said Ross Finman, Founder and CEO at Augmodo. 'We're proud our team achieved our Series A milestone faster than we anticipated and based on these results, we're able to continue growing our technology across the world's most innovative retailers.'
Just last fall, the company raised a $5.3M seed, and followed up with this Series A round less than a year later. Their launch customer, Chemist Warehouse, saw such value in their pilot that they invested in the business after experiencing a significant reduction in stockouts, saving inventory and labor costs. The collaboration has also resulted in the development of a fourth-generation version of the wearable SmartBadge, to be unveiled later this year.
'The simplicity of Augmodo allowed us to test and expand rapidly – and beyond us, we see how that's driving exceptional demand,' said Mark Finocchiaro, Managing Partner, CIO & Director at Chemist Warehouse, Australia's largest pharmacy retailer with 535 locations internationally. 'Augmodo provides preconfigured kits for associates to simply plug in, charge and go. By providing Spatial AI assistants to our associates, Augmodo has made their role even more critical – they can instantly capture invaluable shelf information multiple times daily.'
'We're thrilled to partner with Augmodo as they modernize the largest labor workforce in the world,' said Andrew Marks, Co-Managing Partner at TQ Ventures. 'Our strong retail relationships combined with Augmodo's innovative tech results in a dynamic and strategic partnership that helps retailers and customers provide immediate value today, solving out of stocks, inventory visibility, and in-store tasks, while laying the spatial data groundwork for the future of physical retail. As AI moves into the real world, there is a massive opportunity for enterprise use cases with wearables, the biggest being the physical data challenges in retail.'
SpatialView™ is Augmodo's analytics platform for retail executives and brand partners, which provides real-time visibility into shelf conditions. Instead of having staff travel endlessly to store locations, or viewing week- or month-old data, business leaders can see what's happening in real time inside any store from their laptop.
'Knowing shelf gaps exist so we can diagnose and solve them is one of the biggest challenges of a supplier,' said Christian Armstrong, Chief Customer Officer of L'Oreal Australia / New Zealand. 'We've tried other solutions but they only provide a rearview snapshot – Augmodo allows us to be armed with 24/7 strategic information so we can be agile to customer and store demands – Augmodo is the future.'
This influx of capital will allow Augmodo to continue expanding, scaling to hundreds of stores in 2025, with both brands and retailers, and to more than a thousand in the next 18 months, growing retail channels, geographies, speed and scale.
About Augmodo
Augmodo is the only real-time inventory and task tracker that uses wearable SmartBadge™ on retail associates, creating live 3D store maps with cutting-edge tech to enhance retail experiences and cut costs for retailers, brands and consumers. The spatial AI assistant builds better, more accurate shelf inventory and creates planograms updated dozens of times daily. The Augmodo system is easy to scale, 100X cheaper than alternatives and requires no operational changes. For more information, visit www.augmodo.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
9 minutes ago
- Business Wire
Reddit Accelerates Innovation and Slashes Build Times with Buildkite
SAN FRANCISCO--(BUSINESS WIRE)-- Buildkite Pty Ltd., a leader in scalable software delivery solutions, today announced that Reddit, one of the world's largest online communities with more than over 400M weekly active users, has successfully migrated its mobile continuous integration and delivery (CI/CD) pipelines to Buildkite, dramatically improving build performance, reliability, and developer autonomy across its mobile engineering organization. By adopting Buildkite's high-performance hosted agents and dynamic pipeline primitives, Reddit has reduced build queue times to just seconds and accelerated build speeds by 30% for both Android and iOS workflows, while maintaining cost efficiency. By adopting Buildkite's high-performance hosted agents and dynamic pipeline primitives, Reddit has reduced build queue times to just seconds and accelerated build speeds by 30% for both Android and iOS workflows, while maintaining cost efficiency. Share 'With Buildkite, we finally have the reliability and performance at scale that our mobile teams were missing,' said Ken Struys, Reddit's Director of Developer Experience. 'We've seen a significant improvement to the overall developer experience, and both Android and iOS CI are more than 30% faster on Buildkite.' Facing growing demands from millions of global users and a rapidly expanding codebase, Reddit's mobile teams had outgrown their previous CI/CD provider. Lack of ability to control the build environment meant they couldn't use custom Docker images (as they can with Buildkite). The team also struggled with configuration complexity, with 6,000 lines of YAML split across multiple files, in addition to unreliable builds due to environment drift and dependency failures. Reddit's migration to Buildkite, affecting over 200 mobile engineers, was completed ahead of schedule and involved a full transition of both Android and iOS mono repositories. The company leveraged Buildkite's composable pipeline primitives to create custom workflows that seamlessly integrated with Bazel and BuildBuddy, allowing both iOS and Android apps to be built efficiently on Linux runners with remote execution. Dynamic pipelines enabled Reddit to build powerful CI systems with less cruft and less code repetition. Comprehensive benchmarking revealed that Reddit's builds now run up to 30% faster, with job queue times consistently dropping to around five seconds. Buildkite's Git caching and container caching features were 'absolute game changers,' reducing Git checkout times from several minutes to 30-40 seconds. Intelligent build cancellation and log customization further improved developer experience and operational efficiency. The migration was conducted by a remarkably lean core team. 'We built most of the Android pipelines and the iOS pipelines with two people,' said Struys. 'You don't need massive engineering resources to use Buildkite, but the scale is tremendous. We've got 170 plus engineers on it now, and most of our builds are running like 12 to 15 jobs in each field now.' It was also executed with exceptional care through a staged approach, including having shadow builds running in parallel to production systems to ensure a zero-risk transition. Buildkite's team provided responsive support and delivered custom feature requests, including a GitHub App for GitHub Enterprise Server, throughout the process. "Reddit's successful migration exemplifies the transformative power of modern, composable CI/CD architecture," said Dan Ring, Vice President of Product at Buildkite, who worked closely with the company on the migration. "When engineering organizations outgrow traditional CI/CD limitations, they need a platform that can deliver both immediate performance gains and long-term scalability. Reddit's experience demonstrates what's possible when you combine Buildkite's high-performance hosted agents with our flexible, composable primitives. This isn't just about faster builds, it's about unleashing engineering teams to innovate at the speed their users demand." For more information, see Reddit's blog post here. About Buildkite Pty Ltd: Based in San Francisco and Melbourne, Buildkite is a fast-growing software delivery provider that offers the industry's first and only Scale-Out Delivery Platform. Buildkite's Scale-Out Delivery platform is the only solution that provides the flexibility and scale required by the world's most demanding companies for delivering software across a broad range of use cases, including AI/ML workloads and mobile application development. Global innovation leaders including Airbnb, Block, Canva, Cruise, Culture Amp, Elastic, Lyft, PagerDuty, Pinterest, PlanetScale, Rippling, Shopify, Slack, Tinder, Twilio, Uber, and Wayfair have standardized on Buildkite for software delivery. For more information, please visit


Business Wire
9 minutes ago
- Business Wire
Mortgage Rates Drop to Lowest Level in 10 Months, Upping Purchasing Power in a Buyer-Friendly Market
SEATTLE--(BUSINESS WIRE)--The daily average mortgage rate dropped to 6.57% on August 4, the lowest level in 10 months, according to a new report from Redfin, the real estate brokerage powered by Rocket. That means a homebuyer on a $3,000 monthly budget has gained roughly $20,000 in purchasing power since May, when the daily average rate hit a recent peak of 7.08%. A buyer on that budget can afford a $458,750 home with today's mortgage rate, compared to the $439,000 home they could have bought with May's peak. To look at affordability another way, the monthly mortgage payment on the median-priced U.S. home, which goes for roughly $447,000, is $2,862 with today's average rate. In mid-May, when rates were sitting above 7%, the monthly payment would have been $2,983, over $100 more. Mortgage rates fell over the weekend following a weaker-than-expected July jobs report. The U.S. added fewer jobs than anticipated, and the unemployment rate ticked up, which pushed up the chances of the Fed cutting interest rates in September. 'This dip in mortgage rates gives house hunters a window of opportunity to buy before summer ends,' said Daryl Fairweather, Redfin's chief economist. 'While housing costs are still fairly high, the recent decline in rates boosts purchasing power and improves overall homebuying conditions. Combined with the surplus of homes for sale on the market, serious buyers may want to jump in sooner rather than later.' House hunters should take note that there are hundreds of thousands more home sellers than buyers in the market, giving many prospective buyers an opportunity to negotiate home prices down and ask for concessions. But the gap between sellers and buyers is starting to shrink as new listings decline, with would-be sellers opting to stay put instead of listing their home in a buyer's market. To view the full report, including a chart, please visit: About Redfin Redfin is a technology-driven real estate company with the country's most-visited real estate brokerage website. As part of Rocket Companies (NYSE: RKT), Redfin is creating an integrated homeownership platform from search to close to make the dream of homeownership more affordable and accessible for everyone. Redfin's clients can see homes first with on-demand tours, easily apply for a home loan with Rocket Mortgage, and save thousands in fees while working with a top local agent. You can find more information about Redfin and get the latest housing market data and research at For more information about Rocket Companies, visit


Business Upturn
10 minutes ago
- Business Upturn
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe
Concept Medical announces first patient enrollment in MAGICAL-SV IDE trial, expanding its Coronary Clinical Program across the U.S. and Europe. Business Wire India Concept Medical Inc. , a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA's IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical's mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. Dr. Samin Sharma enrolled the first patient at New York's Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatment options for patients with small-vessel coronary artery disease. 'Today marks a great feat for us and for the MAGICAL-SV trial,' said Dr. Samin Sharma. 'My team at Mount Sinai is privileged to be the first to begin this study. This is a proud moment for all of us, especially knowing what the trial signifies and aims to achieve by evaluating MagicTouch as a potential alternative for treating small vessels in the U.S.' Concept Medical is now actively enrolling in three IDE trials concurrently in the U.S., across coronary and peripheral interventions, underscoring its commitment to bringing innovative therapies to patients worldwide. MAGICAL-SV is a prospective, multicenter, single-blind randomized trial (2:1 randomization) comparing Concept Medical's MagicTouch sirolimus-coated balloon to DES (Everolimus eluting stents [EES] or Zotarolimus eluting stents [ZES]) for the treatment of small coronary artery lesions. Randomization is stratified by study site and presence of medically-treated diabetes mellitus status. The trial will enroll 1,605 patients across the U.S. and Europe, to evaluate the primary endpoint of target lesion failure (TLF) at 12 months. An international team of renowned cardiologists, Dr. Martin B. Leon (USA) – Study Chair, with principal investigators (PI) Dr. Azeem Latib (USA), Dr. Ajay Kirtane (USA), and Prof. Antonio Colombo (Europe) will lead the MAGICAL-SV trial. Dr. Azeem Latib, a U.S. PI for MAGICAL-SV, noted, 'The first U.S. patient enrollment in the MAGICAL-SV study marks an exciting step forward in building robust evidence for SCB technology in the treatment of small-vessel coronary disease. As we explore metal-free PCI strategies, this study brings renewed hope for safer, more effective options for our patients.' Prof. Antonio Colombo, who leads the European arm, added, 'Starting small and going big! MAGICAL-SV represents an important step in building evidence for sirolimus-coated balloons.' This milestone embodies a 'leave nothing behind' philosophy in coronary interventions, treating arterial blockages without permanent implants and addressing the limitations of metallic stents in small vessels. Dr. Martin B. Leon, the Study Chair, emphasized evaluating a no-stent strategy through this trial: 'The initiation of the MAGICAL-SV trial marks an important step in evaluating sirolimus-coated balloon therapy for small coronary vessels. By addressing key limitations of stenting in this complex anatomy, the study aims to generate strong comparative data versus DES. The results could inform future treatment strategies in the U.S. and Europe, offering clinicians a potential alternative for managing small-vessel disease.' The pioneering MAGICAL-SV trial aims to yield strong clinical evidence for sirolimus-coated balloon therapy, supporting Pre-Market Approval (PMA) for MagicTouch SCB in small vessels and potentially redefining CAD treatment. Dr. Manish Doshi, Founder and MD of Concept Medical, said, "MAGICAL-SV marks another step in our mission to redefine vascular care. We're focused on delivering next-generation solutions, helping clinicians achieve better outcomes and give CAD patients a better quality of life." For media inquiries contact: [email protected] Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash